Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, O Supply Disruption — Lowlite Investments, Inc. D/B
Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, O Supply Disruption — Lowlite Investments, Inc. D/B is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, O; Manufacturer: Lowli
| Drug name | Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, O |
|---|---|
| Manufacturer | Lowlite Investments, Inc. D/B/A Olympia Pharmacy |
| Recall/Disruption reason | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-694-2013 |
| Initiation date | 20130529 |
| Quantity affected | 1 |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →